Matur RV, Thuluva S, Gunneri S, Yerroju V, et al. Immunogenicity and safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14) administered to 6-8 weeks old healthy Indian Infants: A single blind, randomized, active-controlled, Phase-III study. Vaccine 2024 Apr 17:S0264-410X(24)00362-1. doi: 10.1016/j.vaccine.2024.
PMID: 38637211